Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms-Reference-Cited by-同舟云学术

Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms

Published:2015-02-17 Issue:5 Volume:61 Page:1615-1626
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mukhopadhyay Bani¹,Schuebel Kornel²,Mukhopadhyay Partha¹,Cinar Resat¹,Godlewski Grzegorz¹,Xiong Keming¹,Mackie Ken³,Lizak Martin⁴,Yuan Qiaoping²,Goldman David²,Kunos George¹

Affiliation:

1. Laboratory of Physiologic Studies; National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; Bethesda MD

2. Laboratory of Neurogenetics; National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; Bethesda MD

3. Gill Center for Biomolecular Science; Indiana University; Bloomington IN

4. In Vivo NMR Center; National Institute on Neurological Diseases and Stroke, National Institutes of Health; Bethesda MD.

Publisher

Wiley

Subject

Hepatology

Reference40 articles.

1. World Health Organization http://www.who.int/mediacentre/factsheets/fs297/en/ 2014

2. http://www.cancer.org/research/cancerfactsfigures/cancer-facts-figures-2013

3. Liver transplantation for malignancy;Hertl;Oncologist,2005

4. Hepatocellular carcinoma pathogenesis: from genes to environment;Farazi;Nat Rev Cancer,2006

5. Alcohol and hepatocellular carcinoma;Morgan;Gastroenterology,2004

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis and experimental validation of the innate immune gene PSMD1 in liver hepatocellular carcinoma and pan-cancer;Heliyon;2023-11

2. Cannabis in the Treatment of Various Cancers and its Current Global Scenario;Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach;2023-10-31

3. Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status;PLOS ONE;2023-10-05

4. Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome;Frontiers in Psychiatry;2023-10-03

5. Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics;Frontiers in Psychiatry;2023-09-05